Bellerophon Therapeutics
BLPH
#10594
Rank
โ‚ฌ0.12 M
Marketcap
0,01031ย โ‚ฌ
Share price
-36.84%
Change (1 day)
-81.82%
Change (1 year)

EPS for Bellerophon Therapeutics (BLPH)

EPS in 2023 (TTM): -0,83ย โ‚ฌ

According to Bellerophon Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,72ย โ‚ฌ. In 2017 the company made an earnings per share (EPS) of -17,78ย โ‚ฌ an increase over its 2016 EPS that were of -20,61ย โ‚ฌ.

EPS history for Bellerophon Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,83ย โ‚ฌ
2017-17,78ย โ‚ฌ-13.75%
2016-20,61ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Baxter
BAX
-0,57ย โ‚ฌ-21.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
1,19ย โ‚ฌ-265.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
6,92ย โ‚ฌ-1,059.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Lantheus Holdings
LNTH
2,10ย โ‚ฌ-391.67%๐Ÿ‡บ๐Ÿ‡ธ USA